Dudediligence.

Unicycive Therapeutics, Inc

UNCYNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$4.1MSep ’24−$21.5MDec ’24$570,000Mar ’25−$6.4MJun ’25−$6.0MSep ’25−$14.7MDec ’25−$12.8MMar ’26−$1.7MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenuenone on file$951,000$675,000none on filenone on file
Operating income−$9.0M−$18.1M−$20.8M−$32.1M−$29.5M
Net income−$10.0M−$18.1M−$30.5M−$36.7M−$26.6M
Operating cash flow−$5.8M−$15.7M−$18.3M−$28.6M−$31.3M
Free cash flow−$5.8M−$15.7M−$18.3M−$28.6M−$31.3M
Cash$16.6M$455,000$9.7M$26.1M$29.2M
Shares outstanding15.0M15.2M34.8M11.4M22.1M